{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:37:38Z","timestamp":1779932258787,"version":"3.53.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The recent conflicting data on the mortality benefit of neuromuscular blocking agents in acute respiratory distress syndrome and the potential adverse effects of continuous neuromuscular blocking agent necessitates that these medications should be used judiciously with dose reduction in mind. The aims of the study were to improve the process of care by provider education of neuromuscular blocking agent titration and monitoring and to determine the impact of clinical endpoint based neuromuscular blocking agent titration protocol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>We conducted a proof-of-concept historically controlled study of protocol-based intervention standardizing paralytic monitoring and titration using clinical variables. Education of the protocol was provided to ICU staff via bedside teaching and workshops. The primary outcomes were the time to reach goal paralysis and cumulative neuromuscular blocking agent dose. Secondary outcomes included maintenance of deeper sedation (Richmond Agitation and Sedation Scale \u20135) prior to neuromuscular blocking agent initiation, total time on mechanical ventilation, length of stay, and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Medical ICU at a quaternary academic hospital between March 2019 and June 2020.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Adult severe acute respiratory distress syndrome (Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>\/F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> &lt;150) patients requiring neuromuscular blocking agent for greater than or equal to 12 hours. Eighty-two patients fulfilled inclusion criteria, 46 in the control group and 36 in the intervention group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Education and implementation of standardized protocol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Compared with the control group, the time to reach goal paralysis in the intervention group was shorter (8.55 \u00b1 9.4 vs 2.63 \u00b1 5.9\u2009hr; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) on significantly lower dose of cisatracurium (total dose 1,897.96 \u00b1 1,241.0 vs 562.72 \u00b1 546.7\u2009mg; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001 and the rate 5.84 \u00b1 2.66 vs 1.99 \u00b1 0.95 \u00b5g\/kg\/min; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001). Deeper sedation was achieved at the time of initiation of neuromuscular blocking agent in the intervention arm (mean Richmond Agitation and Sedation Scale \u20133.3 \u00b1 1.9 vs \u20134.3 \u00b1 1.7; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.015). There was no significant difference in total time on mechanical ventilation, length of ICU stay, length of hospital stay, and mortality between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Implementation of comprehensive education, standardization of sedation prior to neuromuscular blocking agent initiation, integration of clinical variables in determining paralysis achievement, and proper use of peripheral nerve stimulation served as optimal strategies for the titration and monitoring of neuromuscular blocking agent in acute respiratory distress syndrome. This reduced drug utilization while continuing to achieve benefit without causing adverse effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000371","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T22:02:38Z","timestamp":1616191358000},"page":"e0371","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients"],"prefix":"10.1097","volume":"3","author":[{"given":"Sarah","family":"Hadique","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, West Virginia University, Morgantown, WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Badami","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, West Virginia University, Morgantown, WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forte","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, West Virginia University, Morgantown, WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kovacic","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West Virginia University, Morgantown, WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Umer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West Virginia University, Morgantown WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Shigle","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West Virginia University, Morgantown, WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Gardo","sequence":"additional","affiliation":[{"name":"Department of Nursing, West Virginia University, Morgantown WV."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sangani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, West Virginia University, Morgantown, WV."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4187\/respcare.04716","article-title":"Past and present ARDS mortality rates: A systematic review.","volume":"62","author":"M\u00e1ca","year":"2017","journal-title":"Respir Care"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome: Advances in diagnosis and treatment.","volume":"319","author":"Fan","year":"2018","journal-title":"JAMA"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome.","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jcrc.2018.10.019","article-title":"Neuromuscular blocking agents for acute respiratory distress syndrome.","volume":"49","author":"Torbic","year":"2019","journal-title":"J Crit Care"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40560-020-0431-z","article-title":"Neuromuscular blockade in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials.","volume":"8","author":"Ho","year":"2020","journal-title":"J Intensive Care"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13054-020-2765-2","article-title":"Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: A meta-analysis of randomized trials.","volume":"24","author":"Chang","year":"2020","journal-title":"Crit Care"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"e0227664","DOI":"10.1371\/journal.pone.0227664","article-title":"Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.","volume":"15","author":"Hua","year":"2020","journal-title":"PLoS One"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","article-title":"Early neuromuscular blockade in the acute respiratory distress syndrome.","volume":"380","author":"Moss","year":"2019","journal-title":"N Engl J Med"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.CCM.0000196830.61965.F1","article-title":"Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients.","volume":"34","author":"Mehta","year":"2006","journal-title":"Crit Care Med"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/CCM.0000000000002027","article-title":"Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.","volume":"44","author":"Murray","year":"2016","journal-title":"Crit Care Med"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1213\/ANE.0b013e3181da832d","article-title":"Residual neuromuscular block: Lessons unlearned. Part I: Definitions, incidence, and adverse physiologic effects of residual neuromuscular block.","volume":"111","author":"Murphy","year":"2010","journal-title":"Anesth Analg"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0885066603251200","article-title":"National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.","volume":"18","author":"Rhoney","year":"2003","journal-title":"J Intensive Care Med"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/CCM.0B013E3181653895","article-title":"Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome.","volume":"36","author":"Arroliga","year":"2008","journal-title":"Crit Care Med"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"291","DOI":"10.21037\/atm.2017.07.19","article-title":"Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.","volume":"5","author":"Bourenne","year":"2017","journal-title":"Ann Transl Med"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/bja\/42.11.967","article-title":"Stimulus frequency in the detection of neuromuscular block in humans.","volume":"42","author":"Ali","year":"1970","journal-title":"Br J Anaesth"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00002727-200208000-00004","article-title":"National practice with assessment and monitoring of neuromuscular blockade.","volume":"25","author":"Foster","year":"2002","journal-title":"Crit Care Nurs Q"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00003246-199704000-00005","article-title":"A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.","volume":"25","author":"Rudis","year":"1997","journal-title":"Crit Care Med"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1164\/ajrccm.156.5.9701079","article-title":"Comparison of train-of-four and best clinical assessment during continuous paralysis.","volume":"156","author":"Strange","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.126.4.1267","article-title":"A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis.","volume":"126","author":"Baumann","year":"2004","journal-title":"Chest"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13613-017-0234-0","article-title":"Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: A prospective descriptive study.","volume":"7","author":"Bouju","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003246-200201000-00021","article-title":"Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.","volume":"30","author":"Murray","year":"2002","journal-title":"Crit Care Med"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4037\/ajcc2006.15.1.86","article-title":"Patients\u2019 recollections of therapeutic paralysis in the intensive care unit.","volume":"15","author":"Ballard","year":"2006","journal-title":"Am J Crit Care"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/CCM.0000000000004335","article-title":"The reemergence of ketamine for treatment in critically ill adults.","volume":"48","author":"Hurth","year":"2020","journal-title":"Crit Care Med"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.CCM.0000164543.14619.00","article-title":"Daily cost of an intensive care unit day: The contribution of mechanical ventilation.","volume":"33","author":"Dasta","year":"2005","journal-title":"Crit Care Med"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5152\/TJAR.2019.80445","article-title":"Cost analysis on intensive care unit costs based on the length of stay.","volume":"47","author":"Kili\u00e7","year":"2019","journal-title":"Turk J Anaesthesiol Reanim"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:11:50Z","timestamp":1723075910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000371","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}